Michael Klichinsky's Insider Trades & SAST Disclosures

Michael Klichinsky's most recent trade in Carisma Therapeutics Inc was a trade of 221,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 28, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Carisma Therapeutics Inc
Michael Klichinsky Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2025 221,000 221,000 - - Stock Option (Right to Buy)
Carisma Therapeutics Inc
Michael Klichinsky Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 85,000 85,000 - - Stock Option (Right to Buy)
Carisma Therapeutics Inc
Klichinsky Michael Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 170,500 170,500 - - Stock Option (Right to Buy)
Carisma Therapeutics Inc
Michael Klichinsky Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 238,000 238,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades